Abstract: The present invention relates to a method for increasing the expression of a protein in cells, preferably in eukaryotic cells, by reducing the number of RNase L cleavage sites in the coding and/or non-coding region of the nucleic acid sequence of said protein. Furthermore, it relates to nucleic acid sequences exhibiting a reduced number of RNase L cleavage sites as well as to the proteins translated from such sequences.
Type:
Grant
Filed:
January 19, 2010
Date of Patent:
July 29, 2014
Assignees:
King Faisal Specialist Hospital & Research Centre, Terramark Markencreation GmbH
Abstract: The present invention relates to a method for rapid immunochromatographic detection of a target in a sample, wherein the target is an antibody and/or an antigen, using different colloidal gold conjugates conjugated with a specific antibody and some oligonucleotides and their complementary oligonucleotides and/or antibodies and their related antigens, rapid immunochromatographic detection devices, uses of the method for detecting diseases or specific conditions, and a method for the manufacture of the devices as well as a kit which comprises the devices.
Type:
Application
Filed:
December 6, 2007
Publication date:
March 25, 2010
Applicants:
The Jordanian Pharmaceutical Manufacturing Co., Terramark Markencreation GmbH
Inventors:
Adnan Badwan, Murshed Abdel-Qader Mohammed
Abstract: The present invention relates to a method for rapid immunochromatographic detection of a target in a sample by double sandwich immunoassay detection, wherein the target is an antibody and/or an antigen, using different colloidal gold conjugates conjugated with a first and a second specific antibody or antigen and with at least one oligonucleotide and its at least one complementary oligonucleotide and/or at least one non-specific antibody and its related non-specific antigen, to a rapid immunochromatographic detection device, to uses of the method for detecting diseases or specific conditions, and to a method for the manufacture of the device as well as to a kit which comprises the device.
Type:
Application
Filed:
December 6, 2007
Publication date:
March 18, 2010
Applicants:
The Jordanian Pharmaceutical Manufacturing Co., Terramark Markencreation GmbH
Inventors:
Adnan Badwan, Murshed Abdel-Qader Mohammed
Abstract: The present invention refers to a rapid immunochromatographic test device for antigen detection, comprising a first and a second conjugate releasing pad, wherein the first conjugate pad comprises a gold conjugated protein linked first oligonucleotide and a gold conjugated antigen specific antibody, and the second conjugate pad comprises a gold conjugated protein linked second oligonucleotide, which second oligonucleotide is complementary to the first oligonucleotide. The present invention further refers to a use of such test device for antigen detection in urine or saliva, e.g. human choriogonadotropin (hCG) in urine. Embodiments of the test device are a test strip and a detection cup. The present invention also refers to a method for manufacturing such test device.
Type:
Application
Filed:
December 6, 2007
Publication date:
March 18, 2010
Applicants:
The Jordanian Pharmaceutical Manufacturing Co., Terramark Markencreation GmbH
Inventors:
Adnan Badwan, Murshed Abdel-Qader Mohammed
Abstract: The present invention relates to a rapid immunochromatographic test device suitable to detect an antibody and/or antigen in at least one sample, uses of said device for detecting diseases in a sample, a method for the production of said device as well as a kit comprising the device.
Type:
Application
Filed:
December 6, 2007
Publication date:
February 25, 2010
Applicants:
The Jordanian Pharmaceutical Manufacturing Co., Terramark Markencreation GmbH
Inventors:
Adnan Badwan, Murshed Abdel-Qader Mohammed